These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22634159)

  • 1. Perspectives on carbon nanotube-mediated adverse immune effects.
    Andersen AJ; Wibroe PP; Moghimi SM
    Adv Drug Deliv Rev; 2012 Dec; 64(15):1700-5. PubMed ID: 22634159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation by carbon nanotubes.
    Rybak-Smith MJ; Sim RB
    Adv Drug Deliv Rev; 2011 Sep; 63(12):1031-41. PubMed ID: 21669239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalization impacts the effects of carbon nanotubes on the immune system of rainbow trout, Oncorhynchus mykiss.
    Klaper R; Arndt D; Setyowati K; Chen J; Goetz F
    Aquat Toxicol; 2010 Oct; 100(2):211-7. PubMed ID: 20732719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemotoxicity of carbon nanotubes.
    Bussy C; Methven L; Kostarelos K
    Adv Drug Deliv Rev; 2013 Dec; 65(15):2127-34. PubMed ID: 24211768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Material properties in complement activation.
    Moghimi SM; Andersen AJ; Ahmadvand D; Wibroe PP; Andresen TL; Hunter AC
    Adv Drug Deliv Rev; 2011 Sep; 63(12):1000-7. PubMed ID: 21689701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses of BALB/c mice to subcutaneously injected multi-walled carbon nanotubes.
    Meng J; Yang M; Jia F; Xu Z; Kong H; Xu H
    Nanotoxicology; 2011 Dec; 5(4):583-91. PubMed ID: 21034373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When carbon nanotubes encounter the immune system: desirable and undesirable effects.
    Dumortier H
    Adv Drug Deliv Rev; 2013 Dec; 65(15):2120-6. PubMed ID: 24056183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of carbon nanotube-induced toxicity: focus on pulmonary inflammation.
    Bhattacharya K; Andón FT; El-Sayed R; Fadeel B
    Adv Drug Deliv Rev; 2013 Dec; 65(15):2087-97. PubMed ID: 23751779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-walled carbon nanotube surface control of complement recognition and activation.
    Andersen AJ; Robinson JT; Dai H; Hunter AC; Andresen TL; Moghimi SM
    ACS Nano; 2013 Feb; 7(2):1108-19. PubMed ID: 23301860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers.
    Simeonova PP; Erdely A
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():68-73. PubMed ID: 19558236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: The contribution of physico-chemical characteristics.
    Johnston HJ; Hutchison GR; Christensen FM; Peters S; Hankin S; Aschberger K; Stone V
    Nanotoxicology; 2010 Jun; 4(2):207-46. PubMed ID: 20795897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon nanotubes: engineering biomedical applications.
    Gomez-Gualdrón DA; Burgos JC; Yu J; Balbuena PB
    Prog Mol Biol Transl Sci; 2011; 104():175-245. PubMed ID: 22093220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of functionalization of carbon nanotubes with psychosine on complement activation and protein adsorption.
    Rybak-Smith MJ; Tripisciano C; Borowiak-Palen E; Lamprecht C; Sim RB
    J Biomed Nanotechnol; 2011 Dec; 7(6):830-9. PubMed ID: 22416583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon nanotubes as nanomedicines: from toxicology to pharmacology.
    Lacerda L; Bianco A; Prato M; Kostarelos K
    Adv Drug Deliv Rev; 2006 Dec; 58(14):1460-70. PubMed ID: 17113677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The biocompatibility of carbon nanotubes].
    Sun L; Zhang Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):742-6. PubMed ID: 18693469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased macrophage density on carbon nanotube patterns on polycarbonate urethane.
    Kim JY; Khang D; Lee JE; Webster TJ
    J Biomed Mater Res A; 2009 Feb; 88(2):419-26. PubMed ID: 18306321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nanotubes and occupational medicine].
    Borrelli I
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):851-2. PubMed ID: 18409997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tunable chemistry and morphology of multi-wall carbon nanotubes as a route to non-toxic, theranostic systems.
    Boncel S; Müller KH; Skepper JN; Walczak KZ; Koziol KK
    Biomaterials; 2011 Oct; 32(30):7677-86. PubMed ID: 21764122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential pulmonary effects of engineered carbon nanotubes: in vitro genotoxic effects.
    Sargent LM; Reynolds SH; Castranova V
    Nanotoxicology; 2010 Dec; 4():396-408. PubMed ID: 20925447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo behavior of large doses of ultrashort and full-length single-walled carbon nanotubes after oral and intraperitoneal administration to Swiss mice.
    Kolosnjaj-Tabi J; Hartman KB; Boudjemaa S; Ananta JS; Morgant G; Szwarc H; Wilson LJ; Moussa F
    ACS Nano; 2010 Mar; 4(3):1481-92. PubMed ID: 20175510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.